Literature DB >> 30215968

Bone Cancer: Diagnosis and Treatment Principles.

Jason L Ferguson1, Sean P Turner2.   

Abstract

Primary bone cancers include osteosarcoma, Ewing sarcoma, and chondrosarcoma. They account for less than 1% of diagnosed cancers each year and are associated with significant morbidity and mortality. Timely diagnosis is challenging because of late patient presentation, nonspecific symptoms that mimic common musculoskeletal injuries, and low suspicion by physicians. Plain radiography is the preferred diagnostic test. Radiographic suspicion of a bone malignancy should prompt quick referral to a cancer center for multidisciplinary care. Osteosarcoma, the most common bone cancer, most often occurs in children and adolescents. It typically develops in the metaphysis of long bones, specifically the distal femur, proximal tibia, and proximal humerus. Metastasis to the lungs is common. Use of neoadjuvant and adjuvant chemotherapy, in combination with surgery, has improved survival rates to nearly 80% for patients with localized disease, and 90% to 95% of patients do not require limb amputation. Ewing sarcoma is the second most common bone cancer and is similar to osteosarcoma in terms of presenting symptoms, age at occurrence, and treatment. Prognosis for osteosarcoma and Ewing sarcoma depends on the presence of metastasis, which lowers the five-year survival rate to 20% to 30%. Chondrosarcoma is the rarest bone cancer, primarily affecting adults older than 40 years. Survival rates are higher because most of these tumors are low-grade lesions.

Entities:  

Mesh:

Year:  2018        PMID: 30215968

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  49 in total

Review 1.  Imaging following surgery for primary appendicular bone tumours.

Authors:  Imran Khan; Craig Gerrand; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2021-01-22       Impact factor: 2.199

Review 2.  The role of T-LAK cell-originated protein kinase in targeted cancer therapy.

Authors:  Lu Zhang; Fei Wang; Huijun Yi; Svetlana P Ermakova; Olesya S Malyarenko; Jianmei Mo; Yingze Huang; Qiuhong Duan; Juanjuan Xiao; Feng Zhu
Journal:  Mol Cell Biochem       Date:  2022-01-17       Impact factor: 3.396

3.  LncRNA MATN1-AS1 for Prediction of Prognosis in Osteosarcoma Patients and Its Cellular Function.

Authors:  Yongxiang Liu; Dawei Wang; Qinghui Ji; Jinglong Yan
Journal:  Mol Biotechnol       Date:  2021-09-20       Impact factor: 2.695

4.  Construction of a Diagnostic Model for Distinguishing Benign or Malignant Bone Cancer by Mining miRNA Expression Data.

Authors:  Yueming Zhang; Jianwei Hu; Tao Li; Shizhu Hao; Xiaotang Wu
Journal:  Biochem Genet       Date:  2022-07-21       Impact factor: 2.220

Review 5.  Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies.

Authors:  Ingrid Lilienthal; Nikolas Herold
Journal:  Int J Mol Sci       Date:  2020-09-19       Impact factor: 5.923

6.  TRIM68, PIKFYVE, and DYNLL2: The Possible Novel Autophagy- and Immunity-Associated Gene Biomarkers for Osteosarcoma Prognosis.

Authors:  Jie Jiang; Dachang Liu; Guoyong Xu; Tuo Liang; Chaojie Yu; Shian Liao; Liyi Chen; Shengsheng Huang; Xuhua Sun; Ming Yi; Zide Zhang; Zhaojun Lu; Zequn Wang; Jiarui Chen; Tianyou Chen; Hao Li; Yuanlin Yao; Wuhua Chen; Hao Guo; Chong Liu; Xinli Zhan
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

7.  Do Not Miss the Tumor: A Novel Presentation of Osteosarcoma.

Authors:  Michael DePalma; Sachin Gupta; Jie Nguyen; Divya Talwar; Alexandre Arkader; Lawrence Wells
Journal:  Case Rep Pediatr       Date:  2021-05-13

8.  Hsa_circ_0010220 regulates miR-198/Syntaxin 6 axis to promote osteosarcoma progression.

Authors:  Zhaoan Lu; Chuanwen Wang; Xiaolong Lv; Wen Dai
Journal:  J Bone Oncol       Date:  2021-04-22       Impact factor: 4.072

Review 9.  In vitro three-dimensional cell cultures for bone sarcomas.

Authors:  Javier Munoz-Garcia; Camille Jubelin; Aurélie Loussouarn; Matisse Goumard; Laurent Griscom; Axelle Renodon-Cornière; Marie-Françoise Heymann; Dominique Heymann
Journal:  J Bone Oncol       Date:  2021-07-06       Impact factor: 4.072

10.  Ginsenoside Rg5 Inhibits Human Osteosarcoma Cell Proliferation and Induces Cell Apoptosis through PI3K/Akt/mTORC1-Related LC3 Autophagy Pathway.

Authors:  Ming-Yang Liu; Fei Liu; Yan-Jiao Li; Jia-Ning Yin; Yan-Li Gao; Xin-Yue Wang; Chen Yang; Jian-Guo Liu; Hai-Jun Li
Journal:  Oxid Med Cell Longev       Date:  2021-06-25       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.